← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #161 OF 1,000 MOST-CITED

Complete test data included in records

FDA cited this observation 146 times across 135 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs146
BY FISCAL YEAR
FY20268
FY202514
FY202418
FY202312
FY20228
FY202111
FY20208
FY201925
FY201826
FY201716

How FDA worded it — real examples

Laboratory records do not include complete data derived from all tests, examinations and assay necessary to assure compliance with established specifications and standards.

Canyon Rush, LLC · Rush, New York · Drugs · 2026-05-15

Laboratory records do not include complete data derived from all tests, examinations and assay necessary to assure compliance with established specifications and standards.

Alcami Carolinas Corporation · Charleston, South Carolina · Drugs · 2026-04-22

Laboratory records do not include complete data derived from all tests, examinations and assay necessary to assure compliance with established specifications and standards.

Rohto-Mentholatum (Vietnam) Co., Ltd. · Ho Chi Minh · Drugs · 2026-04-14

Laboratory records do not include complete data derived from all tests, examinations and assay necessary to assure compliance with established specifications and standards.

Benuvia Operations, LLC · Round Rock, Texas · Drugs · 2026-01-23

Laboratory records do not include complete data derived from all tests, examinations and assay necessary to assure compliance with established specifications and standards. Electronic records are used, but they do not meet audit trail requirements to ensure that they are trustworthy, reliable and generally equivalent to paper records.

PTI Georgia, LLC · Royston, Georgia · Drugs · 2026-01-16

Laboratory records do not include complete data derived from all tests, examinations and assay necessary to assure compliance with established specifications and standards.

Laboratorios Jaloma S.A. de C.V. · Guadalajara · Drugs · 2025-12-19

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharma industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →